Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy
Ioannides, Zara A, Csurhes, Peter A, Douglas, Nanette L, Mackenroth, Gem, Swayne, Andrew, Thompson, Kate M, Hopkins, Tracey J, Green, Kerryn A, Blum, Stefan, Hooper, Kaye D, Wyssusek, Kerstin H, Coulthard, Alan, Pender, Michael P
Published in Frontiers in neurology (15.03.2021)
Published in Frontiers in neurology (15.03.2021)
Get full text
Journal Article
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Pender, Michael P, Csurhes, Peter A, Smith, Corey, Douglas, Nanette L, Neller, Michelle A, Matthews, Katherine K, Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J, Blum, Stefan, Green, Kerryn A, Ioannides, Zara A, Swayne, Andrew, Aftab, Blake T, Hooper, Kaye D, Burrows, Scott R, Thompson, Kate M, Coulthard, Alan, Khanna, Rajiv
Published in JCI insight (15.10.2020)
Published in JCI insight (15.10.2020)
Get full text
Journal Article
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Pender, Michael P, Csurhes, Peter A, Smith, Corey, Douglas, Nanette L, Neller, Michelle A, Matthews, Katherine K, Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J, Blum, Stefan, Green, Kerryn A, Ioannides, Zara A, Swayne, Andrew, Aftab, Blake T, Hooper, Kaye D, Burrows, Scott R, Thompson, Kate M, Coulthard, Alan, Khanna, Rajiv
Published in JCI insight (15.11.2018)
Published in JCI insight (15.11.2018)
Get full text
Journal Article